Literature DB >> 4285231

Retinal disease in neurology.

G Morgan.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 4285231      PMCID: PMC1899045     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  14 in total

1.  Pheochromocytoma associated with multiple neurofibromatosis and intracranial hemangioma.

Authors:  R C CHAPMAN; V E KEMP; I TALIAFERRO
Journal:  Am J Med       Date:  1959-06       Impact factor: 4.965

2.  Studies in Tay-Sachs diseases. III. Biochemistry. B. Catabolism of gangliosides and related compounds.

Authors:  S R KOREY; A STEIN
Journal:  J Neuropathol Exp Neurol       Date:  1963-01       Impact factor: 3.685

3.  Studies in Tay-Sachs disease. II. Ultrastructure of the cerebrum.

Authors:  R D TERRY; M WEISS
Journal:  J Neuropathol Exp Neurol       Date:  1963-01       Impact factor: 3.685

4.  Toxoplasmosis: the nature of virulence.

Authors:  H E KAUFMAN; J S REMINGTON; L JACOBS
Journal:  Am J Ophthalmol       Date:  1958-11       Impact factor: 5.258

5.  Cytomegalic inclusion disease uveitis; report of a case with isolation from aqueous humor of the virus in tissue culture.

Authors:  R P BURNS
Journal:  AMA Arch Ophthalmol       Date:  1959-03

6.  Retinal dysplasia.

Authors:  A B REESE; B R STRAATSMA
Journal:  Am J Ophthalmol       Date:  1958-04       Impact factor: 5.258

7.  Pheochromocytoma; its relationship to the neurocutaneous syndromes.

Authors:  A S GLUSHIEN; M M MANSUY; D S LITTMAN
Journal:  Am J Med       Date:  1953-03       Impact factor: 4.965

8.  Disseminated cytomegalic inclusion disease in an adult; with primary refractory anemia and transfusional siderosis; report of a case.

Authors:  J P WYATT; F A HEMSATH; M D SOASH
Journal:  Am J Clin Pathol       Date:  1951-01       Impact factor: 2.493

9.  Von Recklinghausen's disease; its relationship to other types of neuroectodermal dysplasia.

Authors:  G E HEIN; J C REAVIS
Journal:  Am Pract Dig Treat       Date:  1950-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.